Truncated ErbB2 expressed in tumor cell nuclei contributes to acquired therapeutic resistance to ErbB2 kinase inhibitors.
Mol Cancer Ther
; 10(8): 1367-74, 2011 Aug.
Article
in En
| MEDLINE
| ID: mdl-21673090
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Receptor, ErbB-2
/
Protein Kinase Inhibitors
/
Antineoplastic Agents
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Mol Cancer Ther
Journal subject:
ANTINEOPLASICOS
Year:
2011
Type:
Article
Affiliation country:
United States